3 results
To investigate whether peri-operative dosing using a population-based pharmacokinetic model (non-linear mixed effect modelling) in hemophilia patients leads to a significant reduction in clotting factor consumption in comparison to the standard…
DDAVP treatment combined with FVIII clotting factor concentrates in patients with mild hemophilia A.
Primary objectives:To assess the proportion of non-severe hemophilia A patients within FVIII target levels with the DDAVP and FVIII concentrate combination treatment in the first 72 hours after the start of combination treatment, without adding off-…
To evaluate the safety and tolerability of single ascending doses of UCB7853 administered as an iv infusion in healthy male study participantsTo evaluate the safety and tolerability of multiple (3 in total, given monthly) ascending doses of UCB7853…